Latin American Cannabis Co. Blueberries Medical Wraps Up 2023 With Multi-Million Dollar Private Placement Deal
Latin American Cannabis Co. Blueberries Medical Wraps Up 2023 With Multi-Million Dollar Private Placement Deal
Latin American licensed producer of medicinal cannabis and cannabis-derived products Blueberries Medical Corp. (CSE:BBM) (OTC:BBRRF) (FRA: 1OA) wrapped up 2023 with an announcement of a non-brokered private placement consisting of the sale of 180,716,00 common shares at CA$0.011 ($0.0083) per common share for aggregate gross proceeds of approximately CA$1,987,876.
拉丁美洲持牌药用大麻和大麻衍生产品生产商蓝莓医疗公司（CSE: BBM）（场外交易代码：BBRRF）（FRA：1OA）在2023年结束时宣布进行非经纪私募配售，包括以每股普通股0.011加元（0.0083美元）出售180,716,00股普通股，总收益约为1,987,876加元。
The net proceeds from the sale of the common shares will be used to repay existing debt and for general corporate and working capital purposes.
出售普通股的净收益将用于偿还现有债务以及一般公司和营运资金用途。
The offering was led by Terraflos Inc., a company with operations throughout Latin America founded and controlled by Facundo Garreton, who serves as chairman, CEO and director of Blueberries.
此次发行由Terraflos Inc. 牵头，该公司在拉丁美洲开展业务，由蓝莓董事长、首席执行官兼董事法昆多·加雷顿创立和控制。
Terraflos is exploring various prospects in Argentina, Mexico and Brazil with plans to expand operations into those markets in the short term.
Terraflos正在阿根廷、墨西哥和巴西探索各种前景，并计划在短期内将业务扩展到这些市场。
See also: Exclusive: LatAm Cannabis Co. Terraflos, Founded By Former Congressman, Closes $8M Seed Funding Round
另见：独家：LatAm Cannabis Co.由前国会议员创立的Terraflos完成了800万美元的种子轮融资
The company's objective is to satisfy food and medicine needs using non-conventional methods, without exploiting natural resources as is common in current methodologies.
该公司的目标是使用非常规方法满足食品和药品需求，而不像当前方法那样开采自然资源。
Earlier this year, Blueberries signed a joint venture agreement with Allied Corp. (OTCQB:ALID). The collaboration includes the production of psychoactive and non-psychoactive derivatives.
今年早些时候，蓝莓与联合公司（OTCQB: ALID）签署了合资协议。该合作包括生产精神活性和非精神活性衍生物。
By combining Allied's expertise in producing quality cannabis flowers with Blueberries' extraction facilities, the companies have joined forces in sales efforts, while optimizing production capabilities.
通过将Allied在生产优质大麻花方面的专业知识与蓝莓的提取设施相结合，两家公司联手开展了销售工作，同时优化了生产能力。
Related News
相关新闻
- Blueberries Medical Q2 Revenue Grows 169%, What About Net Loss?
- Blueberries Provides Corporate Update, Extends Maturity Date Of Convertible Debentures
- Blueberries Medical Reports Q1 2022 Financial Results, Eyes On Argentina's New Medicinal Market
- Blueberries Medical Reports 110% Revenue Growth In 2021
- 蓝莓医疗第二季度收入增长169％，净亏损呢？
- 蓝莓提供公司最新情况，延长可转换债券的到期日
- 蓝莓医学报告2022年第一季度财务业绩，着眼于阿根廷的新药市场
- 蓝莓医疗报告称，2021年收入增长110％
BBRRF Price Action
BBRRF 价格走势
Blueberries Medical's shares traded 12.7451% higher at $0.0138 per share after the market closed on Friday.
周五收盘后，蓝莓医疗的股价上涨了12.7451％，至每股0.0138美元。
Missed the first wave of cannabis investments? Don't make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
Just this year, the PotProfits portfolio has seen smoking-hot gains like:
错过了第一波大麻投资浪潮？别再犯那个错误了。
专家认为，大麻库存已经找到了底线，现在有望实现前所未有的增长。
加入 Benzinga PotProfits。我们的内部大麻股票专家迈克尔·伯杰（Michael Berger）的使命是发现即使在低迷的市场中也有望增长的最有前途的大麻股票。他不遗余力地为你带来最有潜力的两位数机会！
就在今年，PotProfits投资组合的涨幅火爆，例如：
- 47.10% with $GTBIF
- 40.23% with $TCNNF
- 21.50% with $VFF
- 47.10% 使用 $GTBIF
- 使用 $TCNNF 获得 40.23%
- 21.50% 使用 $VFF
But here's the kicker: Michael is about to release his next potential winners, and he's chomping at the bit to share these ticker symbols with you ASAP.
但关键在于：迈克尔即将发布他的下一个潜在赢家，他正在努力尽快与你分享这些股票代码。
Don't miss out on the green rush!
千万不要错过绿色热潮！